Researchers at BYU have devised a system to speed up the process of making life-saving vaccines for new viruses.
Their concept is to create the biological machinery for vaccine production en masse, put it in a freeze-dried state and stockpile it around the country. Then, when a new virus hits, labs can simply add water to a “kit” to rapidly produce vaccines.
“You could just pull it off the shelf and make it,” said senior author Brad Bundy, associate professor of chemical engineering. “We could make the vaccine and be ready for distribution in a day.”
The research, published in Biotechnology Journal, demonstrates the ability to store the drug and vaccine-making machinery for more than a year.
Traditional systems to produce vaccines for pandemic influenza strains require heavy engineering and specialized equipment that only a few labs across the country have on hand. These traditional systems are also time-consuming, taking months to execute.
Bundy’s idea is a new angle on the emerging method of “cell-free protein synthesis,” a process that combines DNA to make proteins needed for drugs (instead of growing protein in a cell). His lab is creating a system where the majority of the work is done beforehand so vaccine kits can be ready to go and be activated at the drop of a dime.
“It will not only provide a quicker response to pandemics, but it will also make protein-based drugs more available to third-world countries where production and refrigerated storage can be problematic,” added William Pitt, a study coauthor and fellow BYU professor of chemical engineering.
While the team is now testing their version of the cell-free, recombinant DNA process for vaccine production, they’ve already successfully demonstrated it for at least one anti-cancer protein (onconase).
The researchers believe their method can significantly reduce investment of time and money towards future drug production and, in turn, reduce treatment expenses for patients.
“The drugs today are changing,” Bundy said. “The lifesaving cancer drugs we have now, the drugs for arthritis, the drugs with the greatest impact, are made out of proteins, not small chemical molecules. This method takes full advantage of that to provide a quicker, more personal response.”
Read more: BYU researchers speeding up process of making vaccines
The Latest on: Making vaccines
[google_news title=”” keyword=”Making vaccines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Making vaccines
- Moderna says FDA delayed RSV vaccine approval to end of Mayon May 10, 2024 at 4:00 am
The FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent its approval, the biotech company said.
- Sanofi forges $1.2bn alliance with vaccines firm Novavaxon May 10, 2024 at 3:07 am
Sanofi has licensed joint commercial rights to Novavax’ COVID-19 vaccine and will work with the biotech on the development of combined flu/COVID shots in a deal worth up to $1.2 billion. The new ...
- Whooping cough deaths ‘will rise’ after ‘worst outbreak for 40 years’ kills 5 babies – as doctors make vaccine pleaon May 10, 2024 at 2:01 am
DISEASE experts have warned that the number of whooping cough deaths ‘may well rise’ as England faces its worst outbreak in 40 years. It comes after reports that five British babies ...
- The WHO’s naive global vaccine plan won’t withstand contact with realityon May 9, 2024 at 11:39 am
The AstraZeneca vaccine was, for a while, the most celebrated product in Britain. The UK was one of only a handful of countries with the skills and apparatus not just to invent an effective Covid jab ...
- New mRNA vaccine for deadly brain cancer triggers a strong immune responseon May 9, 2024 at 4:00 am
The vaccine, which was described in a study published on May 1 in the journal Cell, was created by extracting genetic material called RNA from a tumor from a patient with glioblastoma, an aggressive ...
- Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Downon May 9, 2024 at 3:00 am
The biotech’s first product for something other than Covid doesn’t clearly perform any better than other shots on the market.
- Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeaston May 8, 2024 at 12:01 pm
Researchers say new yeast biosynthetic platform provides "vast opportunities" to produce structural variants of QS-21 and identify new adjuvant leads.
- A tailored vaccine shows promise in treating childhood eczemaon May 8, 2024 at 1:06 am
Researchers say a new "tailored" vaccine shows promise in treating eczema flares caused by a certain bacteria in children ...
- An adjuvant made in yeast could lower vaccine cost and boost availabilityon May 7, 2024 at 5:00 pm
Adjuvants make vaccines more effective, though one of the best is an expensive extract from the soap bark tree. To lower the cost and avoid the laborious extraction process from bark, UC Berkeley and ...
- Bird Flu: U.S. Could Produce and Ship 100 Million Vaccine Doses Within Monthson May 7, 2024 at 8:56 am
There is no sign that the H5N1 bird flu circulating in dairy cow herds is developing the ability to spread easily to people. But federal health officials are planning for the rollout of a bird flu ...
via Bing News